These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12018460)

  • 1. A mouse model for infectious mononucleosis.
    Flaño E; Woodland DL; Blackman MA
    Immunol Res; 2002; 25(3):201-17. PubMed ID: 12018460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine gamma-herpesvirus infection causes V(beta)4-specific CDR3-restricted clonal expansions within CD8(+) peripheral blood T lymphocytes.
    Hardy CL; Silins SL; Woodland DL; Blackman MA
    Int Immunol; 2000 Aug; 12(8):1193-204. PubMed ID: 10917894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis.
    Stewart JP; Silvia OJ; Atkin IM; Hughes DJ; Ebrahimi B; Adler H
    J Virol; 2004 Oct; 78(19):10449-59. PubMed ID: 15367611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.
    Flaño E; Husain SM; Sample JT; Woodland DL; Blackman MA
    J Immunol; 2000 Jul; 165(2):1074-81. PubMed ID: 10878386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
    Rajćáni J; Kúdelová M
    Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination.
    Stewart JP; Micali N; Usherwood EJ; Bonina L; Nash AA
    Vaccine; 1999 Jan; 17(2):152-7. PubMed ID: 9987149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the host response to a gamma-herpesvirus.
    Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
    Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine gamma-herpesvirus infection.
    Hardy CL; Flaño E; Cardin RD; Kim IJ; Nguyen P; King S; Woodland DL; Blackman MA
    Viral Immunol; 2001; 14(4):391-402. PubMed ID: 11792068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious mononucleosis and Epstein-Barr virus.
    Vetsika EK; Callan M
    Expert Rev Mol Med; 2004 Nov; 6(23):1-16. PubMed ID: 15541197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell reactivity during infectious mononucleosis and persistent gammaherpesvirus infection in mice.
    Flaño E; Hardy CL; Kim IJ; Frankling C; Coppola MA; Nguyen P; Woodland DL; Blackman MA
    J Immunol; 2004 Mar; 172(5):3078-85. PubMed ID: 14978113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.
    Fischer F; Mücke J; Werny L; Gerrer K; Mihatsch L; Zehetmaier S; Riedel I; Geisperger J; Bodenhausen M; Schulte-Hillen L; Hoffmann D; Protzer U; Mautner J; Behrends U; Bauer T; Körber N
    Virol J; 2024 Jun; 21(1):139. PubMed ID: 38877590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection.
    Forrest C; Hislop AD; Rickinson AB; Zuo J
    PLoS Pathog; 2018 Sep; 14(9):e1007110. PubMed ID: 30248160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen expression during murine gamma-herpesvirus infection.
    Woodland DL; Flaño E; Usherwood EJ; Liu Luzheng ; Kim IJ; Husain SM; Sample JT; Blackman MA
    Immunobiology; 2001 Dec; 204(5):649-58. PubMed ID: 11846230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
    Samreen B; Tao S; Tischer K; Adler H; Drexler I
    Front Immunol; 2019; 10():2984. PubMed ID: 31921215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis.
    Casiraghi C; Shanina I; Cho S; Freeman ML; Blackman MA; Horwitz MS
    PLoS Pathog; 2012; 8(5):e1002715. PubMed ID: 22615572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.
    Wu TT; Usherwood EJ; Stewart JP; Nash AA; Sun R
    J Virol; 2000 Apr; 74(8):3659-67. PubMed ID: 10729142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.